Abstract
Pediatric Blood & CancerVolume 56, Issue 7 p. 1151-1151 Letter to the Editor Treatment of primary CNS lymphoma with high-dose methotrexate in immunocompetent patients Ian Joseph Cohen MB, ChB, Corresponding Author Ian Joseph Cohen MB, ChB icohen@tau.ac.il Department of Pediatric Hematology-Oncology, Schneider Children's Medical Center of Israel, Petah Tikva and Sackler Faculty of Medicine, Tel Aviv University, Ramat Aviv, IsraelDepartment of Pediatric Hematology-Oncology, Schneider Children's Medical Center of Israel, 14 Kaplan St, Petah Tikva 49202, Israel.===Search for more papers by this author Ian Joseph Cohen MB, ChB, Corresponding Author Ian Joseph Cohen MB, ChB icohen@tau.ac.il Department of Pediatric Hematology-Oncology, Schneider Children's Medical Center of Israel, Petah Tikva and Sackler Faculty of Medicine, Tel Aviv University, Ramat Aviv, IsraelDepartment of Pediatric Hematology-Oncology, Schneider Children's Medical Center of Israel, 14 Kaplan St, Petah Tikva 49202, Israel.===Search for more papers by this author First published: 10 February 2011 https://doi.org/10.1002/pbc.23001Read the full textAboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onFacebookTwitterLinked InRedditWechat No abstract is available for this article. Volume56, Issue71 July 2011Pages 1151-1151 RelatedInformation
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
